Showing results (71-80 of 185) with videos related to
Sort By:
Pageof 19
Oncology|August 30, 2019
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.Scientific Reports|July 2, 2016
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseHirotaka Shoji, Sachiyo Yoshio, Yohei Mano, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 30, 2019
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matchingToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.Cancer Medicine|May 26, 2019
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.Journal of Medical Virology|March 6, 2026
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus InfectionHidenori Toyoda, Akito Nozaki, Atsushi Hiraoka, et al.Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.Oncology|February 26, 2020
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular CarcinomaAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.Liver Cancer|February 20, 2020
Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with LenvatinibAtsushi Hiraoka, Takashi Kumada, Shinya Fukunishi, et al.Infectious Diseases and Therapy|November 3, 2020
Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter StudyToshifumi Tada, Takashi Kumada, Hiroaki Okushin, et al.Plos One|September 10, 2021
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis CMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.Pageof 19